ONCBeOne Medicines Ltd.

$32B

Q3 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$54M-75.4% YoY

Gross Profit

-$102M-188.4% margin

Operating Income

-$151M-278.8% margin

Net Income

-$144M-265.7% margin

EPS (Diluted)

$-2.47

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

-$132M

Free Cash Flow

-$159M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$425M

Stockholders' Equity

$2.0B

Cash & Equivalents

$643M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$220M	-75.4%
Gross Profit	-$102M	$131M	-178.2%
Operating Income	-$151M	$115M	-231.5%
Net Income	-$144M	$117M	-222.7%

ONC Q3 2018 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena